Chelation Therapy with Oral Solution of Deferiprone in Transfusional Iron-Overloaded Children with Hemoglobinopathies
Iron overload in hemoglobinopathies is secondary to blood transfusions, chronic hemolysis, and increased iron absorption and leads to tissue injury requiring the early use of chelating agents. The available agents are parenteral deferoxamine and oral deferiprone and deferasirox. There are limited da...
Saved in:
| Main Authors: | Alexandros Makis, Nikolaos Chaliasos, Sapfo Alfantaki, Paraskevi Karagouni, Antigone Siamopoulou |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2013-01-01
|
| Series: | Anemia |
| Online Access: | http://dx.doi.org/10.1155/2013/121762 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
VCAM-1 and ICAM-1 serum levels as markers of relapse in visceral leishmaniasis
by: Alexandros Makis, et al.
Published: (2017-01-01) -
THE HISTORY OF DEFERIPRONE (L1) AND THE COMPLETE TREATMENT OF IRON OVERLOAD IN THALASSAEMIA
by: George J Kontoghiorghes, et al.
Published: (2020-01-01) -
Deferiprone−Resveratrol Hybrid, an Iron-Chelating Compound, Acts as an Antimalarial and Hepatoprotective Agent in Plasmodium berghei-Infected Mice
by: Hataichanok Chuljerm, et al.
Published: (2022-01-01) -
Severe Thrombocytopenic Purpura in a Child with Brucellosis: Case Presentation and Review of the Literature
by: Alexandros Makis, et al.
Published: (2017-01-01) -
Therapeutic Value of Silymarin as Iron Chelator in Children with Beta Thalassemia with Iron Overload
by: adel abd elhaleim hagag
Published: (2014-08-01)